Industry Alarmed By Third-Party Audit, Registry Provisions In Draft House Bills
This article was originally published in The Gray Sheet
Executive Summary
A House subcommittee released nine pieces of draft FDA legislation June 6, including several provisions that mobilized device industry lobbyists to fight for changes